These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 37742475)

  • 1. Effects of melatonin on dopaminergic neuron development via IP3-mediated mitochondrial Ca
    Dong S; Kifune T; Kato H; Wang L; Kong J; Hirofuji Y; Sun X; Sato H; Ito Y; Kato TA; Sakai Y; Ohga S; Fukumoto S; Masuda K
    Biochem Biophys Res Commun; 2023 Nov; 681():7-12. PubMed ID: 37742475
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Impaired neurite development associated with mitochondrial dysfunction in dopaminergic neurons differentiated from exfoliated deciduous tooth-derived pulp stem cells of children with autism spectrum disorder.
    Nguyen HTN; Kato H; Masuda K; Yamaza H; Hirofuji Y; Sato H; Pham TTM; Takayama F; Sakai Y; Ohga S; Taguchi T; Nonaka K
    Biochem Biophys Rep; 2018 Dec; 16():24-31. PubMed ID: 30258988
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Positive effect of exogenous brain-derived neurotrophic factor on impaired neurite development and mitochondrial function in dopaminergic neurons derived from dental pulp stem cells from children with attention deficit hyperactivity disorder.
    Nguyen Nguyen HT; Kato H; Sato H; Yamaza H; Sakai Y; Ohga S; Nonaka K; Masuda K
    Biochem Biophys Res Commun; 2019 Jun; 513(4):1048-1054. PubMed ID: 31010680
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Mitochondrial Calcium-Triggered Oxidative Stress and Developmental Defects in Dopaminergic Neurons Differentiated from Deciduous Teeth-Derived Dental Pulp Stem Cells with MFF Insufficiency.
    Sun X; Dong S; Kato H; Kong J; Ito Y; Hirofuji Y; Sato H; Kato TA; Sakai Y; Ohga S; Fukumoto S; Masuda K
    Antioxidants (Basel); 2022 Jul; 11(7):. PubMed ID: 35883852
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence od melatonin receptors antagonists, luzindole and 4-phenyl-2-propionamidotetralin (4-P-PDOT), on melatonin-dependent vasopressin and adrenocorticotropic hormone (ACTH) release from the rat hypothalamo-hypophysial system. In vitro and in vivo studies.
    Juszczak M; Roszczyk M; Kowalczyk E; Stempniak B
    J Physiol Pharmacol; 2014 Dec; 65(6):777-84. PubMed ID: 25554981
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Melatonin MT
    López-Canul M; Min SH; Posa L; De Gregorio D; Bedini A; Spadoni G; Gobbi G; Comai S
    Int J Mol Sci; 2019 May; 20(10):. PubMed ID: 31108968
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alterations of melatonin receptors MT1 and MT2 in the hypothalamic suprachiasmatic nucleus during depression.
    Wu YH; Ursinus J; Zhou JN; Scheer FA; Ai-Min B; Jockers R; van Heerikhuize J; Swaab DF
    J Affect Disord; 2013 Jun; 148(2-3):357-67. PubMed ID: 23357659
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Circadian Pattern of Melatonin MT1 and MT2 Receptor Localization in the Rat Suprachiasmatic Nucleus.
    Waly NE; Hallworth R
    J Circadian Rhythms; 2015 Mar; 13():1. PubMed ID: 27103927
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence that membrane-bound G protein-coupled melatonin receptors MT1 and MT2 are not involved in the neuroprotective effects of melatonin in focal cerebral ischemia.
    Kilic U; Yilmaz B; Ugur M; Yüksel A; Reiter RJ; Hermann DM; Kilic E
    J Pineal Res; 2012 Mar; 52(2):228-35. PubMed ID: 21913972
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of melatonin membrane receptors in melatonin-dependent oxytocin secretion from the rat hypothalamo-neurohypophysial system - an in vitro and in vivo approach.
    Juszczak M; Wolak M; Bojanowska E; Piera L; Roszczyk M
    Endokrynol Pol; 2016; 67(5):507-514. PubMed ID: 26884304
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Dysregulation of Circadian Rhythms in Autism Spectrum Disorders.
    Pinato L; Galina Spilla CS; Markus RP; da Silveira Cruz-Machado S
    Curr Pharm Des; 2019; 25(41):4379-4393. PubMed ID: 31682208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Melatonergic Receptors (Mt1/Mt2) as a Potential Additional Target of Novel Drugs for Depression.
    Boiko DI; Shkodina AD; Hasan MM; Bardhan M; Kazmi SK; Chopra H; Bhutra P; Baig AA; Skrypnikov AM
    Neurochem Res; 2022 Oct; 47(10):2909-2924. PubMed ID: 35689787
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic potential of melatonin agonists.
    Cardinali DP; Pandi-Perumal SR; Srinivasan V; Spence DW; Trakht I
    Expert Rev Endocrinol Metab; 2008 Mar; 3(2):269-279. PubMed ID: 30764095
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dysregulation of Neurite Outgrowth and Cell Migration in Autism and Other Neurodevelopmental Disorders.
    Prem S; Millonig JH; DiCicco-Bloom E
    Adv Neurobiol; 2020; 25():109-153. PubMed ID: 32578146
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Sleep well. Untangling the role of melatonin MT1 and MT2 receptors in sleep.
    Gobbi G; Comai S
    J Pineal Res; 2019 Apr; 66(3):e12544. PubMed ID: 30586215
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Melatonin: From Pharmacokinetics to Clinical Use in Autism Spectrum Disorder.
    Lalanne S; Fougerou-Leurent C; Anderson GM; Schroder CM; Nir T; Chokron S; Delorme R; Claustrat B; Bellissant E; Kermarrec S; Franco P; Denis L; Tordjman S
    Int J Mol Sci; 2021 Feb; 22(3):. PubMed ID: 33540815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Selective MT2 melatonin receptor antagonists block melatonin-mediated phase advances of circadian rhythms.
    Dubocovich ML; Yun K; Al-Ghoul WM; Benloucif S; Masana MI
    FASEB J; 1998 Sep; 12(12):1211-20. PubMed ID: 9737724
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Activation of melatonin receptor 2 but not melatonin receptor 1 mediates melatonin-conferred cardioprotection against myocardial ischemia/reperfusion injury.
    Han D; Wang Y; Chen J; Zhang J; Yu P; Zhang R; Li S; Tao B; Wang Y; Qiu Y; Xu M; Gao E; Cao F
    J Pineal Res; 2019 Aug; 67(1):e12571. PubMed ID: 30903623
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Melatonin protects against cisplatin-induced ovarian damage in mice via the MT1 receptor and antioxidant activity.
    Barberino RS; Menezes VG; Ribeiro AEAS; Palheta RC; Jiang X; Smitz JEJ; Matos MHT
    Biol Reprod; 2017 Jun; 96(6):1244-1255. PubMed ID: 28595266
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Relationship between Autism Spectrum Disorder and Melatonin during Fetal Development.
    Jin Y; Choi J; Won J; Hong Y
    Molecules; 2018 Jan; 23(1):. PubMed ID: 29346266
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.